Other S16 Ep55: OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer OncLive PodcastIn this podcast, experts Joyce O'Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A.OtherOncologyRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) OncLive Podcast In this podcast, experts Joyce O’Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A. OtherOncologyRead full story Post navigation Previous: Beyond GLP-1Rs: emerging targets poised to gain share of obesity marketNext: Novo’s late-stage sickle cell win piles pressure on competitors Related Stories Other ‘Seismic shift’ as obesity overtakes cancer for R&D returns pharminent May 5, 2026 Other 223: An Interview With Dr. Antn Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease pharminent May 4, 2026 Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech pharminent April 29, 2026
